Published on June 9, 2017
At the 2017 American Society of Clinical Oncology (ASCO) meeting, leading prostate cancer experts came together to discuss the latest developments in treatment and research.In this roundtable discussion, Patient Power founder Andrew Schorr was joined by leaders in the field: Dr. Philip Kantoff from Memorial Sloan Kettering Cancer Center, Dr. Daniel Petrylakfrom Yale University Cancer Center, Dr. Sumit Subudhi from The University of Texas MD Anderson Cancer Center and Darryl Mitteldorf, Executive Director of Malecare. The panel explores the current research landscape, including progress in immunotherapy, chemotherapy approaches and symptom management.
This roundtable discussion is a Patient Empowerment Network program produced by Patient Power. We thank Sanofi Oncology for their support.